This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by López-Arce, G. Articles by Téllez-Ávila, F. I. Search for Related Content Social Bookmarking                         What's this?

Upper gastrointestinal Dieulafoy's lesions and endoscopic treatment: First report from a Mexican centre

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Sergio Zepeda-Gómez

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Norberto C. Chávez-Tapia

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Sandra García-Osogobio

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Ada M. Franco-Guzmán

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Miguel A. Ramírez-Luna

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Félix I. Téllez-Ávila

Departments of Gastroenterology, Endoscopy and Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico, felixtelleza{at}gmail.com

The aim was to evaluate the initial success, rebleeding rate, need for emergent surgery, and mortality rates of patients with Dieulafoy's lesion (DL) and endoscopic treatment (ET). Patients with DL from a tertiary center were included. We included 20 patients with follow-up of 90 (60—550) days. The lesser curvature was the most common localization. Initial success, rebleeding, and emergent surgery requirement were observed in 90%, 10%, and 15%, respectively. No objective variables were related with response to ET. In conclusion, ET is secure and useful in patients with DL and it must be considered as the first-line treatment modality.

Key Words: Gastrointestinal bleed • Dieulafoy's lesion • endoscopic treatment

Therapeutic Advances in Gastroenterology, Vol. 1, No. 2, 97-101 (2008)
DOI: 10.1177/1756283X08096285


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?